PEOPLE - Changes at JenaValve Technology:
This article was originally published in Clinica
Executive Summary
Germany's JenaValve Technology has established a scientific advisory board, appointing eight members with immediate effect. It is headed by Professor Hans-Reiner Figulla, a cardiologist and co-founder and inventor at the Munich-based minimally-invasive aortic valve replacement systems developer. The other members are: fellow co-founder and inventor Dr Markus Ferrari; stent catheter consultant Dr Younes Boudjemline (Necker Hospital, Paris); Professor Junbo Ge, co-chair of the Shanghai Institute of Cardiovascular Diseases and president of the Shanghai Society of Cardiology; Professor Martin Rothman, director of cardiac R&D at London's Barts hospital; Professor Ziyad Hijazi, of Chicago's Rush University; Professor Jan Gummert, director of cardiothoracic surgery at Friedrich Schiller University Jena, Germany; and Professor Horst Sievert, director of the CardioVascular Center, Frankfurt.
You may also be interested in...
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.